A new strategy developed by Professor Nathan Gianneschi grabs cancer-driving proteins and directs them to the cell’s disposal ...

Cancer Research Institute, New York, NY, USA. The cancer cell therapy landscape continues to evolve rapidly. In 2024, the first approvals of tumour-infiltrating lymphocyte (TIL) and T cell receptor ...

Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By ...

Cancer Center at Illinois (CCIL) members Ratnakar Singh and Michael Spinella collaborated in new research that fills in ...

Gothenburg, February 27, 2026 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company developing next-generation cancer treatments based on its proprietary iTANK platform, tod ...

A new study from researchers at the Hebrew University of Jerusalem provides fresh insight into how pancreatic cancer may ...

Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

UConn Center on Aging researchers have published a new editorial in the journal Aging titled "Polyploidy-induced senescence: Linking development, differentiation, repair, and (possibly) cancer?" In ...

Research has uncovered a surprising biological twist: molecules that help support healthy aging can also contribute to cancer growth.

The National Cancer Institute has quietly moved a familiar and polarizing drug into its preclinical pipeline: ivermectin, long known as a popular dewormer for horses and a standard antiparasitic in ...